Literature DB >> 6511286

Excessive cold pressor responses in the irritable bowel syndrome.

J F Fielding, R Regan.   

Abstract

Entities:  

Mesh：

Year:  1984        PMID： 6511286     DOI： 10.1007/bf02939930

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  5 in total

1.  Psychological characteristics of patients with the irritable bowel syndrome.

Authors:  R L Palmer; E Stonehill; A H Crisp; S L Waller; J J Misiewicz
Journal:  Postgrad Med J       Date:  1974-07       Impact factor: 2.401

2.  Levels of anxiety in colonic disorders.

Authors:  M D Esler; K J Goulston
Journal:  N Engl J Med       Date:  1973-01-04       Impact factor: 91.245

3.  The diagnostic sensitivity of physical signs in the irritable bowel syndrome.

Authors:  J F Fielding
Journal:  Ir Med J       Date:  1981-05

4.  A year in out-patients with the irritable bowel syndrome.

Authors:  J F Fielding
Journal:  Ir J Med Sci       Date:  1977-06       Impact factor: 1.568

5.  Excretion of 4-hydroxy-3 methoxy mandelic acid in cases of ulcerative colitis and diarrhoea of nervous origin.

Authors:  J T Wright; A K Das
Journal:  Gut       Date:  1969-08       Impact factor: 23.059
  5 in total
  3 in total

1.  Single doses of ritodrine delay orocaecal transit in patients with irritable bowel syndrome.

Authors:  G Basilisco; M G Camboni; A Bozzani; M Molgora; P A Bianchi
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

2.  Bronchial hyperresponsiveness in irritable bowel syndrome.

Authors:  Dae Won Jun; Oh Young Lee; Ho Joo Yoon; Hang Lak Lee; Byung Chul Yoon; Ho Soon Choi; Min Ho Lee; Dong Hoo Lee; Choon Suhk Kee
Journal:  Dig Dis Sci       Date:  2005-09       Impact factor: 3.199

3.  Action of centrally mediated autonomic stimulation on human upper gastrointestinal transit: a comparative study of two stimuli.

Authors:  J D O'Brien; D G Thompson; W R Burnham; J Holly; E Walker
Journal:  Gut       Date:  1987-08       Impact factor: 23.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.